Geode Capital Management
RPID icon

Geode Capital Management’s Rapid Micro Biosystems RPID Stock Holding History

Geode Capital Management’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$395K Sell
228,041
-19,136
-8% -$40.3K ﹤0.01% 3692
2026
Q1 		$561K Buy
247,177
+29,609
+14% +$108K ﹤0.01% 3544
2025
Q4 		$631K Buy
217,568
+12,881
+6% +$44.7K ﹤0.01% 3513
2025
Q3 		$684K Buy
204,687
+608
+0.3% +$1.92K ﹤0.01% 3509
2025
Q2 		$704K Buy
204,079
+3,143
+2% +$9.12K ﹤0.01% 3445
2025
Q1 		$531K Buy
200,936
+47,824
+31% +$109K ﹤0.01% 3517
2024
Q4 		$138K Buy
153,112
+2,454
+2% +$2.47K ﹤0.01% 4007
2024
Q3 		$134K Sell
150,658
-19,914
-12% -$15.5K ﹤0.01% 4024
2024
Q2 		$113K Buy
170,572
+9,419
+6% +$8.05K ﹤0.01% 4104
2024
Q1 		$156K Buy
161,153
+5,889
+4% +$5.72K ﹤0.01% 4017
2023
Q4 		$115K Hold
155,264
– – ﹤0.01% 4141
2023
Q3 		$168K Buy
155,264
+58,616
+61% +$58.3K ﹤0.01% 4050
2023
Q2 		$96.6K Hold
96,648
– – ﹤0.01% 4345
2023
Q1 		$127K Sell
96,648
-1,273
-1% -$1.65K ﹤0.01% 4251
2022
Q4 		$110K Buy
97,921
+5,477
+6% +$13.3K ﹤0.01% 4363
2022
Q3 		$298K Sell
92,444
-8
-0% -$31 ﹤0.01% 3989
2022
Q2 		$397K Sell
92,452
-134,551
-59% -$626K ﹤0.01% 3889
2022
Q1 		$1.54M Buy
227,003
+81,641
+56% +$601K ﹤0.01% 3390
2021
Q4 		$1.55M Buy
145,362
+47,606
+49% +$743K ﹤0.01% 3504
2021
Q3 		$1.8M Buy
+97,756
New +$2.02M ﹤0.01% 3399

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EFA
Evernest Financial Advisors Carmel, Indiana $478M AUM 24% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management's RPID Position: Q2 2026 in Review

Geode Capital Management reduced its Rapid Micro Biosystems (RPID) stake by 7.7% in Q2 2026, selling an estimated $40.3K and leaving 228,041 shares worth $395K. The position accounts for ﹤0.01% of the portfolio, ranked #3692.

Geode Capital Management first reported a position in RPID in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.8M in Q3 2021. 34 funds tracked by Wall St. Rank hold RPID as of Q2 2026.

  • Geode Capital Management held 228,041 shares of Rapid Micro Biosystems worth $395K as of Q2 2026.
  • Geode Capital Management sold 19,136 Rapid Micro Biosystems shares in Q2 2026, an estimated $40.3K.
  • Rapid Micro Biosystems made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3692 holding.
  • Geode Capital Management first reported a position in Rapid Micro Biosystems in Q3 2021 and has held it in 20 quarters since.
  • Geode Capital Management's Rapid Micro Biosystems position peaked at $1.8M in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.